Centre for International Health, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway
School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
BMJ Open. 2024 May 1;14(5):e080510. doi: 10.1136/bmjopen-2023-080510.
Non-communicable diseases (NCDs) constitute approximately 74% of global mortality, with 77% of these deaths occurring in low-income and middle-income countries. Tanzania exemplifies this situation, as the percentage of total disability-adjusted life years attributed to NCDs has doubled over the past 30 years, from 18% to 36%. To mitigate the escalating burden of severe NCDs, the Tanzanian government, in collaboration with local and international partners, seeks to extend the integrated package of essential interventions for severe NCDs (PEN-Plus) to district-level facilities, thereby improving accessibility. This study aims to estimate the cost of initiating PEN-Plus for rheumatic heart disease, sickle cell disease and type 1 diabetes at Kondoa district hospital in Tanzania.
We will employ time-driven activity-based costing (TDABC) to quantify the capacity cost rates (CCR), and capital and recurrent costs associated with the implementation of PEN-Plus. Data on resource consumption will be collected through direct observations and interviews with nurses, the medical officer in charge and the heads of laboratory and pharmacy units/departments. Data on contact times for targeted NCDs will be collected by observing a sample of patients as they move through the care delivery pathway. Data cleaning and analysis will be done using Microsoft Excel.
Ethical approval to conduct the study has been waived by the Norwegian Regional Ethics Committee and was granted by the Tanzanian National Health Research Ethics Committee NIMR/HQ/R.8a/Vol.IX/4475. A written informed consent will be provided to the study participants. This protocol has been disseminated in the Bergen Centre for Ethics and Priority Setting International Symposium, Norway and the 11th Muhimbili University of Health and Allied Sciences Scientific Conference, Tanzania in 2023. The findings will be published in peer-reviewed journals for use by the academic community, researchers and health practitioners.
非传染性疾病(NCDs)约占全球死亡率的 74%,其中 77%的死亡发生在低收入和中等收入国家。坦桑尼亚就是这种情况的一个例子,在过去 30 年中,NCDs 导致的总伤残调整生命年(DALY)百分比翻了一番,从 18%增加到 36%。为了减轻严重 NCDs 的不断增加的负担,坦桑尼亚政府与当地和国际合作伙伴合作,试图将严重 NCDs 的综合基本干预包(PEN-Plus)扩展到地区一级的设施,从而提高可及性。本研究旨在估算在坦桑尼亚 Kondoa 地区医院启动 PEN-Plus 治疗风湿性心脏病、镰状细胞病和 1 型糖尿病的成本。
我们将采用时间驱动作业成本法(TDABC)来量化与 PEN-Plus 实施相关的产能成本率(CCR)、资本和经常性成本。资源消耗数据将通过直接观察和访谈护士、负责的医疗官以及实验室和药房单位/部门的负责人收集。针对目标 NCDs 的接触时间数据将通过观察患者在护理提供途径中的移动情况来收集。数据清理和分析将使用 Microsoft Excel 进行。
挪威区域伦理委员会已放弃对本研究进行伦理批准,并已获得坦桑尼亚国家卫生研究伦理委员会 NIMR/HQ/R.8a/Vol.IX/4475 的批准。将向研究参与者提供书面知情同意书。本方案已在挪威卑尔根伦理和优先事项设置国际研讨会以及 2023 年坦桑尼亚第 11 届 Muhimbili 大学健康与联合科学会议上传播。研究结果将发表在同行评议的期刊上,供学术界、研究人员和卫生从业人员使用。